Abstract:In recent years, optical coherence tomography angiography(OCTA)has been extensively adopted in clinical practice. Its core principle is to reconstruct perfusion maps of the retinal vasculature by analyzing temporal fluctuations in optical coherence tomography(OCT)signals, producing visual outcomes comparable to those obtained from conventional fundus angiography. Traditional angiographic modalities including fluorescein angiography(FFA)and indocyanine green angiography(ICGA)play a vital role in diagnosing retinal vascular disorders. Nevertheless, FFA and ICGA rely on intravascular contrast media, which renders them invasive and time-consuming examinations. They also carry potential risks such as hypersensitivity reactions and merely produce two-dimensional en face images withlimited depth resolution, restricting layered vascular segmentation. By contrast, OCTA can acquire three-dimensional imaging data of retinal and choroidal vasculature across distinct ocular layers without intravascular dye injection. It enables accurate depth localization of lesions and captures instantaneous blood flow signals. Furthermore, quantitative metrics extracted from OCTA can reliably characterize the morphological features of intraocular vasculature. Accordingly, OCTA has been broadly utilized for the diagnosis, therapeutic monitoring and follow-up of multiple ocular disorders, including diabetic retinopathy(DR), retinal vein occlusion(RVO), age-related macular degeneration(ARMD)and glaucoma. Nevertheless, OCTA imaging still has inherent drawbacks,such as inability to assess vascular leakage, prominent artifact interference, and limited scanning field of view. This paper systematically reviews the technical evolution and clinical research evidence of OCTA, and explores its potential clinical applications in the future.